Category
Bortezomib
CAS Number
NA
Molecular Formula
C19H24N4O2
Molecular Weight
340.4g/mol
Synonym

N-(1-(Isopentylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide; N-(1-(Isopentylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide; 2-Carboxamide, N-(1-(isopentylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-; 2-Pyrazinecarboxamide, N-[2-[(3-methylbutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-; N-[2-[(3-Methylbutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide

Keywords
boron derivatives
Enzyme inhibitors
Chiral standards
Pharmaceutical Standards
Fine Chemicals
Intermediates
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Isoamylamide Impurity is a chemical by-product that can occur during the synthesis or formulation of Bortezomib. It involves an isoamylamide moiety incorporated into the molecule, either unintentionally or as a side reaction. Such impurities are monitored and controlled because they can affect the drug’s purity, stability, and safety in pharmaceutical products.